Skip to main content
Top
Published in: Techniques in Coloproctology 3/2014

01-03-2014 | Short Communication

Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors

Authors: M. Pedroni, C. Di Gregorio, L. Cortesi, L. Reggiani Bonetti, G. Magnani, M. L. Simone, V. Medici, C. Priore Oliva, M. Marino, M. Ponz de Leon

Published in: Techniques in Coloproctology | Issue 3/2014

Login to get access

Abstract

Germline mutations in BRCA1 and BRCA2 genes predispose to hereditary breast cancer, whereas carriers of mutations in any of the mismatch repair genes (MMR; hMLH1, hMSH2, hMSH6, hPMS2) are highly susceptible to Lynch syndrome. In the present study, we describe a woman affected by unilateral breast cancer at the age of 35 years. After 4 years, during the follow-up she developed synchronous (and asymptomatic) endometrial cancer, ovarian carcinoma and renal clear cell carcinoma. After 7 years (at age 46), the patient developed an infiltrating carcinoma of the contralateral breast and died in a few months of metastatic disease. Initial investigations led to the detection of a constitutional mutation in the BRCA1 gene. The extended genealogical tree disclosed a suspected history of colorectal carcinoma in the maternal branch. Endometrial cancer of the proband was investigated for microsatellite instability (MSI) and immunohistochemical expression of MLH1, MSH2 and MSH6 proteins. An high MSI status and lack of expression of MLH1 protein were detected. hMLH1 gene sequencing revealed the presence of a constitutional mutation, which was also found in the mother of the proband. Loss of the wild-type hMLH1 allele was detected in both breast tumors, thus suggesting that the MMR defect contributed to the development of the breast cancer.
Literature
1.
go back to reference Boyd J, Rubin SC (1997) Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol 64:196–206PubMedCrossRef Boyd J, Rubin SC (1997) Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol 64:196–206PubMedCrossRef
2.
go back to reference Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324PubMedCrossRef Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324PubMedCrossRef
3.
go back to reference Zhang S, Royer R, Li S et al (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121:352–357CrossRef Zhang S, Royer R, Li S et al (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121:352–357CrossRef
4.
go back to reference Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676–689PubMedCentralPubMedCrossRef Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676–689PubMedCentralPubMedCrossRef
5.
go back to reference Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490PubMedCrossRef Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490PubMedCrossRef
6.
go back to reference Barrow E, Alduaij W, Robinson L et al (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 74:233–242PubMedCrossRef Barrow E, Alduaij W, Robinson L et al (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 74:233–242PubMedCrossRef
7.
go back to reference Barrow E, Robinson L, Alduaij W et al (2009) Cumulative life incidence of extracolonic cancer in Lynch syndrome: a of 121 families with proven mutations. Clin Genet 75:141–149PubMedCrossRef Barrow E, Robinson L, Alduaij W et al (2009) Cumulative life incidence of extracolonic cancer in Lynch syndrome: a of 121 families with proven mutations. Clin Genet 75:141–149PubMedCrossRef
8.
go back to reference Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1–18PubMedCentralPubMedCrossRef Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76:1–18PubMedCentralPubMedCrossRef
9.
go back to reference Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary non polyposis colorectal cancer: an update review. Gastroenterology 104:1535–1549PubMed Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary non polyposis colorectal cancer: an update review. Gastroenterology 104:1535–1549PubMed
10.
go back to reference Ligtenberg MJ, Kuiper RP, Chan TL et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 41:112–117PubMedCrossRef Ligtenberg MJ, Kuiper RP, Chan TL et al (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 41:112–117PubMedCrossRef
11.
go back to reference Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P (2013) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome. Dtsch Arztebl Int 110:32–38PubMedCentralPubMed Steinke V, Engel C, Büttner R, Schackert HK, Schmiegel WH, Propping P (2013) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)/Lynch Syndrome. Dtsch Arztebl Int 110:32–38PubMedCentralPubMed
12.
go back to reference Borg A, Isola J, Chen J et al (2000) Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer 85:796–800PubMedCrossRef Borg A, Isola J, Chen J et al (2000) Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer 85:796–800PubMedCrossRef
13.
14.
go back to reference Kast K, Neuhann TM, Gorgens H et al (2012) Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer. BMC Cancer 12:531PubMedCentralPubMedCrossRef Kast K, Neuhann TM, Gorgens H et al (2012) Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer. BMC Cancer 12:531PubMedCentralPubMedCrossRef
15.
16.
go back to reference Xicola RM, Llor X, Pons E et al (2007) Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 99:244–252PubMedCrossRef Xicola RM, Llor X, Pons E et al (2007) Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 99:244–252PubMedCrossRef
17.
go back to reference Findeisen P, Kloor M, Merx S et al (2005) T25 repeat in the 3′untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 65:8072–8078PubMedCrossRef Findeisen P, Kloor M, Merx S et al (2005) T25 repeat in the 3′untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 65:8072–8078PubMedCrossRef
18.
go back to reference Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM (2001) Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci USA 98:5134–5139PubMedCentralPubMedCrossRef Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM (2001) Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci USA 98:5134–5139PubMedCentralPubMedCrossRef
19.
go back to reference Kurzawski G, Suchy J, Kladny J et al (2002) Germline MSH2 and MLH1 mutation spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 39:E65PubMedCentralPubMedCrossRef Kurzawski G, Suchy J, Kladny J et al (2002) Germline MSH2 and MLH1 mutation spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 39:E65PubMedCentralPubMedCrossRef
20.
go back to reference Bonadona V, Bonaïti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305:2304–2310PubMedCrossRef Bonadona V, Bonaïti B, Olschwang S et al (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305:2304–2310PubMedCrossRef
21.
go back to reference Vasen HF, Morreau H, Nortier JW (2001) Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68:1533–1535PubMedCentralPubMedCrossRef Vasen HF, Morreau H, Nortier JW (2001) Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 68:1533–1535PubMedCentralPubMedCrossRef
22.
go back to reference Win AK, Young JP, Lindor NM et al (1012) Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. Clin Oncol 30:958–964CrossRef Win AK, Young JP, Lindor NM et al (1012) Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. Clin Oncol 30:958–964CrossRef
23.
go back to reference Jensen UB, Sunde L, Timshel S et al (2010) Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 120:777–782PubMedCrossRef Jensen UB, Sunde L, Timshel S et al (2010) Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 120:777–782PubMedCrossRef
24.
go back to reference Buerki N, Gautier L, Kovac M et al (2012) Evidence for breast cancer as an integral part of Lynch syndrome. Gene Chromosome Cancer 51:83–91CrossRef Buerki N, Gautier L, Kovac M et al (2012) Evidence for breast cancer as an integral part of Lynch syndrome. Gene Chromosome Cancer 51:83–91CrossRef
Metadata
Title
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors
Authors
M. Pedroni
C. Di Gregorio
L. Cortesi
L. Reggiani Bonetti
G. Magnani
M. L. Simone
V. Medici
C. Priore Oliva
M. Marino
M. Ponz de Leon
Publication date
01-03-2014
Publisher
Springer Milan
Published in
Techniques in Coloproctology / Issue 3/2014
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-013-1030-y

Other articles of this Issue 3/2014

Techniques in Coloproctology 3/2014 Go to the issue